#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13368	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2140	613.2	0	.	n	.	0	C451T	SNP	451	451	C	703	703	T	738	T,C	525,181	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13368	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2140	613.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1436	1436	C	754	C,G	736,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13368	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2140	613.2	0	HET	.	.	.	C1450T	.	1450	1450	C	1702	1702	C	790	C,T	560,199	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24916	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3446	712.6	0	.	n	.	0	T695C	SNP	695	695	T	941	941	C	812	C,G	793,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24916	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3446	712.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2217	2217	C	745	C	717	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24916	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3446	712.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2291	2291	A	754	A	736	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24916	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3446	712.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2843	2843	C	760	C	734	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24916	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3446	712.6	0	HET	.	.	.	A1638G	.	1638	1638	A	1884	1884	A	793	A,G	599,165	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	539	1408	folP	855	855	99.88	folP.l15.c4.ctg.1	1604	86.5	0	.	p	.	0	T66M	NONSYN	196	198	ACG	503	505	ATG	135;133;133	A;T,C;G	134;126,2;130	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	539	1408	folP	855	855	99.88	folP.l15.c4.ctg.1	1604	86.5	1	SNP	p	R229S	1	.	.	685	687	AGC	992	994	AGC	165;167;168	A;G;C	163;164;163	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4268	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3460	122.1	1	SNP	p	S91F	1	.	.	271	273	TTC	602	604	TTC	135;136;135	T;T;C	128;129;125	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4268	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3460	122.1	1	SNP	p	G95N	0	.	.	283	285	GGC	614	616	GGC	130;132;130	G;G;C	123;124;123	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4268	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3460	122.1	1	SNP	p	D95G	1	.	.	283	285	GGC	614	616	GGC	130;132;130	G;G;C	123;124;123	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1290	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1237	102.1	1	SNP	p	G45D	0	.	.	133	135	GGC	385	387	GGC	170;170;170	G;G;C	166;166;164	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	660	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1029	62.9	0	.	n	.	0	A197.	DEL	197	197	A	532	532	A	151	A	149	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4498	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2945	150.5	1	SNP	p	D86N	0	.	.	256	258	GAC	618	620	GAC	152;153;154	G;A;C	149;147;149	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4498	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2945	150.5	1	SNP	p	R87W	0	.	.	259	261	CGT	621	623	CGT	153;149;150	C,A;G;T	148,1;145;144	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4498	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2945	150.5	1	SNP	p	R87I	0	.	.	259	261	CGT	621	623	CGT	153;149;150	C,A;G;T	148,1;145;144	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4498	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2945	150.5	1	SNP	p	S87R	1	.	.	259	261	CGT	621	623	CGT	153;149;150	C,A;G;T	148,1;145;144	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4498	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2945	150.5	1	SNP	p	S88P	0	.	.	262	264	TCC	624	626	TCC	150;150;150	T;C;C	144;143;144	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3194	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2833	111.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1665	1667	GGC	176;173;172	G;G;C	167;163;161	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.35.001	penA.35.001	1	1	27	3150	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2346	132.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1177	1179	GCC	173;174;177	G,A;C;C	169,1;170;174	penA.35.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3150	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2346	132.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1180	1182	ATG	180;179;181	A;T;G	174;176;177	penA.35.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3150	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2346	132.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1192	1194	ACC	183;183;179	A;C;C	175;176;172	penA.35.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3150	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2346	132.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1192	1194	ACC	183;183;179	A;C;C	175;176;172	penA.35.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3150	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2346	132.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1693	1695	ACC	146;144;144	A;C;C	134;139;137	penA.35.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3150	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2346	132.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1747	1749	GCG	116;113;113	G;C,G;G	106;93,1;108	penA.35.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3150	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2346	132.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1747	1749	GCG	116;113;113	G;C,G;G	106;93,1;108	penA.35.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3150	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2346	132.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1870	1872	GGT	124;124;123	G;G;T	120;120;115	penA.35.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3150	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2346	132.0	1	SNP	p	G545S	0	.	.	1633	1635	GGC	1879	1881	GGC	108;106;105	G;G;C	100;103;101	penA.35.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3150	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2346	132.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1897	1899	CCG	91;92;87	C,G;C,G;G	82,2;85,1;75	penA.35.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5272	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3082	168.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1638	1640	CCG	200;196;196	C;C;G	189;189;180	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2022	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1846	107.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	556	556	C	144	C	135	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2934	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1691	170.9	0	.	p	.	0	I45V	NONSYN	133	135	ATT	423	425	GTT	197;198;196	G,A;T;T	190,4;188;193	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2934	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1691	170.9	1	SNP	p	G120K	1	.	.	358	360	AAG	648	650	AAG	201;200;203	A;A;G	192;193;186	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2934	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1691	170.9	1	SNP	p	N121D	0	.	.	361	363	AAC	651	653	AAC	201;200;206	A;A;C	192;195;193	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2934	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1691	170.9	1	SNP	p	A121N	1	.	.	361	363	AAC	651	653	AAC	201;200;206	A;A;C	192;195;193	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9358	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4809	191.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1076	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	995	106.7	1	SNP	p	V57M	1	.	.	169	171	ATG	464	466	ATG	225;225;226	A;T;G	220;217;218	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
